Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Geoffrey Smith

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Vaccinia

Concepts & Ideas

Genes & Molecular Sequences

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Roberts Kim L; Breiman Adrien; Carter Gemma C; Ewles Helen A; Hollinshead Michael; Law Mansun; Smith Geoffrey L
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
Midgley Claire M; Putz Mike M; Weber Jonathan N; Smith Geoffrey L
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.
Jacobs Nathalie; Bartlett Nathan W; Clark Richard H; Smith Geoffrey L
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Geoffrey Smith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Roberts Kim L; Breiman Adrien; Carter Gemma C; Ewles Helen A; Hollinshead Michael; Law Mansun; Smith Geoffrey L
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
The Journal of general virology 2009;90(Pt 7):1582-91.
2008: Midgley Claire M; Putz Mike M; Weber Jonathan N; Smith Geoffrey L
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.
The Journal of general virology 2008;89(Pt 12):2992-7.
2008: Jacobs Nathalie; Bartlett Nathan W; Clark Richard H; Smith Geoffrey L
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection.
The Journal of general virology 2008;89(Pt 11):2877-81.
2008: Fahy Aodhnait S; Clark Richard H; Glyde Emily F; Smith Geoffrey L
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
The Journal of general virology 2008;89(Pt 10):2377-87.
2008: Roberts Kim L; Smith Geoffrey L
Vaccinia virus morphogenesis and dissemination.
Trends in microbiology 2008;16(10):472-9.
2008: Chen Ron A-J; Ryzhakov Grigory; Cooray Samantha; Randow Felix; Smith Geoffrey L
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14.
PLoS pathogens 2008;4(2):e22.
2008: Bahar Mohammad W; Kenyon Julia C; Putz Mike M; Abrescia Nicola G A; Pease James E; Wise Emma L; Stuart David I; Smith Geoffrey L; Grimes Jonathan M
Structure and function of A41, a vaccinia virus chemokine binding protein.
PLoS pathogens 2008;4(1):e5.
2008: Graham Stephen C; Bahar Mohammad W; Cooray Samantha; Chen Ron A-J; Whalen Daniel M; Abrescia Nicola G A; Alderton David; Owens Raymond J; Stuart David I; Smith Geoffrey L; Grimes Jonathan M
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
PLoS pathogens 2008;4(8):e1000128.
2007: Graham Stephen C; Bahar Mohammad W; Abrescia Nicola G A; Smith Geoffrey L; Stuart David I; Grimes Jonathan M
Structure of CrmE, a virus-encoded tumour necrosis factor receptor.
Journal of molecular biology 2007;372(3):660-71.
2007: Froggatt Graham C; Smith Geoffrey L; Beard Philippa M
Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response.
The Journal of general virology 2007;88(Pt 7):1917-21.
2007: Gubser Caroline; Goodbody Rory; Ecker Andrea; Brady Gareth; O'Neill Luke A J; Jacobs Nathalie; Smith Geoffrey L
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.
The Journal of general virology 2007;88(Pt 6):1667-76.
2007: Cooray Samantha; Bahar Mohammad W; Abrescia Nicola G A; McVey Colin E; Bartlett Nathan W; Chen Ron A-J; Stuart David I; Grimes Jonathan M; Smith Geoffrey L
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.
The Journal of general virology 2007;88(Pt 6):1656-66.
2007: Gubser Caroline; Bergamaschi Daniele; Hollinshead Michael; Lu Xin; van Kuppeveld Frank J M; Smith Geoffrey L
A new inhibitor of apoptosis from vaccinia virus and eukaryotes.
PLoS pathogens 2007;3(2):e17.
2006: Fox James M; Najarro Pilar; Smith Geoffrey L; Struyf Sofie; Proost Paul; Pease James E
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
The Journal of biological chemistry 2006;281(48):36652-61.
2006: Pütz Mike M; Midgley Claire M; Law Mansun; Smith Geoffrey L
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination.
Nature medicine 2006;12(11):1310-5.
2006: Beard Philippa M; Froggatt Graham C; Smith Geoffrey L
Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model.
The Journal of general virology 2006;87(Pt 6):1521-9.
2006: Chen Ron A-J; Jacobs Nathalie; Smith Geoffrey L
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor.
The Journal of general virology 2006;87(Pt 6):1451-8.
2006: Jacobs Nathalie; Chen Ron A-J; Gubser Caroline; Najarro Pilar; Smith Geoffrey L
Intradermal immune response after infection with Vaccinia virus.
The Journal of general virology 2006;87(Pt 5):1157-61.
2006: Law Mansun; Carter Gemma C; Roberts Kim L; Hollinshead Michael; Smith Geoffrey L
Ligand-induced and nonfusogenic dissolution of a viral membrane.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(15):5989-94.
2006: Najarro Pilar; Gubser Caroline; Hollinshead Michael; Fox James; Pease James; Smith Geoffrey L
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.
The Journal of general virology 2006;87(Pt 4):809-16.
2006: Ait-Tahar Kamel; Cerundolo Vincenzo; Banham Alison H; Hatton Christian; Blanchard Tom; Kusec Rajko; Becker Marion; Smith Geoffrey L; Pulford Karen
B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
International journal of cancer. Journal international du cancer 2006;118(3):688-95.
2006: Clark Richard H; Kenyon Julia C; Bartlett Nathan W; Tscharke David C; Smith Geoffrey L
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.
The Journal of general virology 2006;87(Pt 1):29-38.
2005: Herrero-Martínez Esteban; Roberts Kim L; Hollinshead Michael; Smith Geoffrey L
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein.
The Journal of general virology 2005;86(Pt 11):2961-8.
2005: Pütz Mike M; Alberini Isabella; Midgley Claire M; Manini Ilaria; Montomoli Emanuele; Smith Geoffrey L
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy.
The Journal of general virology 2005;86(Pt 11):2955-60.
2005: Bartlett Nathan W; Buttigieg Karen; Kotenko Sergei V; Smith Geoffrey L
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
The Journal of general virology 2005;86(Pt 6):1589-96.
2005: Carter Gemma C; Law Mansun; Hollinshead Michael; Smith Geoffrey L
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.
The Journal of general virology 2005;86(Pt 5):1279-90.
2005: Law Mansun; Pütz Mike M; Smith Geoffrey L
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.
The Journal of general virology 2005;86(Pt 4):991-1000.
2004: Smith Geoffrey L; Law Mansun
The exit of vaccinia virus from infected cells.
Virus research 2004;106(2):189-97.
2004: Bartlett Nathan W; Dumoutier Laure; Renauld Jean-Christophe; Kotenko Sergei V; McVey Colin E; Lee Han-Joo; Smith Geoffrey L
A new member of the interleukin 10-related cytokine family encoded by a poxvirus.
The Journal of general virology 2004;85(Pt 6):1401-12.
2004: Law Mansun; Hollinshead Michael; Lee Han-Joo; Smith Geoffrey L
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails.
The Journal of general virology 2004;85(Pt 5):1279-90.
2004: Gubser Caroline; Hué Stéphane; Kellam Paul; Smith Geoffrey L
Poxvirus genomes: a phylogenetic analysis.
The Journal of general virology 2004;85(Pt 1):105-17.
2004: Law Mansun; Smith Geoffrey L
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.
Methods in molecular biology (Clifton, N.J.) 2004;269():187-204.
2003: Najarro Pilar; Lee Han-Joo; Fox James; Pease James; Smith Geoffrey L
Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.
The Journal of general virology 2003;84(Pt 12):3325-36.
2003: Reading Patrick C; Smith Geoffrey L
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.
Journal of virology 2003;77(18):9960-8.
2003: Pires de Miranda Marta; Reading Patrick C; Tscharke David C; Murphy Brendan J; Smith Geoffrey L
The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model.
The Journal of general virology 2003;84(Pt 9):2459-71.
2003: Carter Gemma C; Rodger Gaener; Murphy Brendan J; Law Mansun; Krauss Oliver; Hollinshead Michael; Smith Geoffrey L
Vaccinia virus cores are transported on microtubules.
The Journal of general virology 2003;84(Pt 9):2443-58.
2003: Reading Patrick C; Smith Geoffrey L
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection.
The Journal of general virology 2003;84(Pt 8):1973-83.
2003: McConkey Samuel J; Reece William H H; Moorthy Vasee S; Webster Daniel; Dunachie Susanna; Butcher Geoff; Vuola Jenni M; Blanchard Tom J; Gothard Philip; Watkins Kate; Hannan Carolyn M; Everaere Simone; Brown Karen; Kester Kent E; Cummings James; Williams Jackie; Heppner D Gray; Pathan Ansar; Flanagan Katie; Arulanantham Nirmalan; Roberts Mark T M; Roy Michael; Smith Geoffrey L; Schneider Joerg; Peto Tim; Sinden Robert E; Gilbert Sarah C; Hill Adrian V S
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.
Nature medicine 2003;9(6):729-35.
2003: Reading Patrick C; Moore Jeffrey B; Smith Geoffrey L
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection.
The Journal of experimental medicine 2003;197(10):1269-78.
2003: Reading Patrick C; Symons Julian A; Smith Geoffrey L
A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1435-42.
2003: Smith Geoffrey L; Murphy Brendan J; Law Mansun
Vaccinia virus motility.
Annual review of microbiology 2003;57():323-42.
2002: Smith Geoffrey L; Vanderplasschen Alain; Law Mansun
The formation and function of extracellular enveloped vaccinia virus.
The Journal of general virology 2002;83(Pt 12):2915-31.
2002: Symons Julian A; Adams Elizabeth; Tscharke David C; Reading Patrick C; Waldmann Herman; Smith Geoffrey L
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.
The Journal of general virology 2002;83(Pt 11):2833-44.
2002: Krauss Oliver; Hollinshead Ruth; Hollinshead Michael; Smith Geoffrey L
An investigation of incorporation of cellular antigens into vaccinia virus particles.
The Journal of general virology 2002;83(Pt 10):2347-59.
2002: Goatley Lynnette C; Twigg Steve R F; Miskin James E; Monaghan Paul; St-Arnaud René; Smith Geoffrey L; Dixon Linda K
The African swine fever virus protein j4R binds to the alpha chain of nascent polypeptide-associated complex.
Journal of virology 2002;76(19):9991-9.
2002: Tscharke David C; Reading Patrick C; Smith Geoffrey L
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.
The Journal of general virology 2002;83(Pt 8):1977-86.
2002: Bartlett Nathan; Symons Julian A; Tscharke David C; Smith Geoffrey L
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence.
The Journal of general virology 2002;83(Pt 8):1965-76.
2002: Symons Julian A; Tscharke David C; Price Nicola; Smith Geoffrey L
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.
The Journal of general virology 2002;83(Pt 8):1953-64.
2002: Tscharke David C; Smith Geoffrey L
Notes on transient host range selection for engineering vaccinia virus strain MVA.
BioTechniques 2002;33(1):186-8.
2002: Smith Geoffrey L; McFadden Grant
Smallpox: anything to declare?
Nature reviews. Immunology 2002;2(7):521-7.
2002: Price Nicola; Tscharke David C; Smith Geoffrey L
The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence.
The Journal of general virology 2002;83(Pt 4):873-8.
2002: Gubser Caroline; Smith Geoffrey L
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox.
The Journal of general virology 2002;83(Pt 4):855-72.
2002: Alcamí Antonio; Smith Geoffrey L
The vaccinia virus soluble interferon-gamma receptor is a homodimer.
The Journal of general virology 2002;83(Pt 3):545-9.
2002: Rodger Gaener; Smith Geoffrey L
Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
The Journal of general virology 2002;83(Pt 2):323-32.
2002: Reading Patrick C; Khanna Anu; Smith Geoffrey L
Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence.
Virology 2002;292(2):285-98.
2002: Law Mansun; Hollinshead Ruth; Smith Geoffrey L
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread.
The Journal of general virology 2002;83(Pt 1):209-22.
2002: van Eijl Henriette; Hollinshead Michael; Rodger Gaener; Zhang Wei-Hong; Smith Geoffrey L
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface.
The Journal of general virology 2002;83(Pt 1):195-207.
2001: Schneider J; Langermans J A; Gilbert S C; Blanchard T J; Twigg S; Naitza S; Hannan C M; Aidoo M; Crisanti A; Robson K J; Smith G L; Hill A V; Thomas A W
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
Vaccine 2001;19(32):4595-602.
2001: Ng A; Tscharke D C; Reading P C; Smith G L
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence.
The Journal of general virology 2001;82(Pt 9):2095-105.
2001: Gardner J D; Tscharke D C; Reading P C; Smith G L
Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model.
The Journal of general virology 2001;82(Pt 9):2083-93.
2001: Almazán F; Tscharke D C; Smith G L
The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication.
Journal of virology 2001;75(15):7018-29.
2001: Hollinshead M; Rodger G; Van Eijl H; Law M; Hollinshead R; Vaux D J; Smith G L
Vaccinia virus utilizes microtubules for movement to the cell surface.
The Journal of cell biology 2001;154(2):389-402.
2001: Mathew E C; Sanderson C M; Hollinshead R; Smith G L
A mutational analysis of the vaccinia virus B5R protein.
The Journal of general virology 2001;82(Pt 5):1199-213.
2001: Potter P; Tourdot S; Blanchard T; Smith G L; Gould K G
Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
The Journal of general virology 2001;82(Pt 5):1069-74.
2001: Lee H J; Essani K; Smith G L
The genome sequence of Yaba-like disease virus, a yatapoxvirus.
Virology 2001;281(2):170-92.
2001: Law M; Smith G L
Antibody neutralization of the extracellular enveloped form of vaccinia virus.
Virology 2001;280(1):132-42.
2000: Zhang W H; Wilcock D; Smith G L
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.
Journal of virology 2000;74(24):11654-62.
2000: Alcamí A; Symons J A; Smith G L
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.
Journal of virology 2000;74(23):11230-9.
2000: Dorrell L; O'Callaghan C A; Britton W; Hambleton S; McMichael A; Smith G L; Rowland-Jones S; Blanchard T J
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
Vaccine 2000;19(2-3):327-36.
2000: van Eijl H; Hollinshead M; Smith G L
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.
Virology 2000;271(1):26-36.
2000: Price N; Tscharke D C; Hollinshead M; Smith G L
Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
Virology 2000;267(1):65-79.
2000: Sanderson C M; Hollinshead M; Smith G L
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles.
The Journal of general virology 2000;81(Pt 1):47-58.
1999: Mathew E C; Sanderson C M; Hollinshead R; Hollinshead M; Grimley R; Smith G L
The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
Virology 1999;265(1):131-46.
1999: Tscharke D C; Smith G L
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae.
The Journal of general virology 1999;80 ( Pt 10)():2751-5.
1999: Hanke T; Samuel R V; Blanchard T J; Neumann V C; Allen T M; Boyson J E; Sharpe S A; Cook N; Smith G L; Watkins D I; Cranage M P; McMichael A J
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
Journal of virology 1999;73(9):7524-32.
1999: Wilcock D; Duncan S A; Traktman P; Zhang W H; Smith G L
The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.
The Journal of general virology 1999;80 ( Pt 8)():2137-48.
1999: Alcamí A; Khanna A; Paul N L; Smith G L
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors.
The Journal of general virology 1999;80 ( Pt 4)():949-59.
1999: Gilbert S C; Schneider J; Plebanski M; Hannan C M; Blanchard T J; Smith G L; Hill A V
Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
Biological chemistry 1999;380(3):299-303.
1999: Goatley L C; Marron M B; Jacobs S C; Hammond J M; Miskin J E; Abrams C C; Smith G L; Dixon L K
Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5.
The Journal of general virology 1999;80 ( Pt 3)():525-35.
1999: Hanke T; Neumann V C; Blanchard T J; Sweeney P; Hill A V; Smith G L; McMichael A
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.
Vaccine 1999;17(6):589-96.
1999: Hollinshead M; Vanderplasschen A; Smith G L; Vaux D J
Vaccinia virus intracellular mature virions contain only one lipid membrane.
Journal of virology 1999;73(2):1503-17.
1999: Smith G L
Vaccinia virus immune evasion.
Immunology letters 1999;65(1-2):55-62.
1999: Smith G L; Symons J A; Alcamí A
Immune modulation by proteins secreted from cells infected by vaccinia virus.
Archives of virology. Supplementum 1999;15():111-29.
1998: Sanderson C M; Smith G L
Vaccinia virus induces Ca2+-independent cell-matrix adhesion during the motile phase of infection.
Journal of virology 1998;72(12):9924-33.
1998: Vanderplasschen A; Mathew E; Hollinshead M; Sim R B; Smith G L
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7544-9.
1998: Sanderson C M; Frischknecht F; Way M; Hollinshead M; Smith G L
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.
The Journal of general virology 1998;79 ( Pt 6)():1415-25.
1998: Jacobs S C; Dixon L K; Brookes S M; Smith G L
Expression of African swine fever virus envelope protein j13L inhibits vaccinia virus morphogenesis.
The Journal of general virology 1998;79 ( Pt 5)():1169-78.
1998: Blanchard T J; Alcami A; Andrea P; Smith G L
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.
The Journal of general virology 1998;79 ( Pt 5)():1159-67.
1998: Vanderplasschen A; Hollinshead M; Smith G L
Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
The Journal of general virology 1998;79 ( Pt 4)():877-87.
1998: Schneider J; Gilbert S C; Blanchard T J; Hanke T; Robson K J; Hannan C M; Becker M; Sinden R; Smith G L; Hill A V
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
Nature medicine 1998;4(4):397-402.
1998: Mathew E; Sanderson C M; Hollinshead M; Smith G L
The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Journal of virology 1998;72(3):2429-38.
1998: Hanke T; Blanchard T J; Schneider J; Hannan C M; Becker M; Gilbert S C; Hill A V; Smith G L; McMichael A
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.
Vaccine 1998;16(5):439-45.
1998: Sanderson C M; Way M; Smith G L
Virus-induced cell motility.
Journal of virology 1998;72(2):1235-43.
1998: Alcamí A; Symons J A; Collins P D; Williams T J; Smith G L
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(2):624-33.
1998: Hanke T; Blanchard T J; Schneider J; Ogg G S; Tan R; Becker M; Gilbert S C; Hill A V; Smith G L; McMichael A
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
The Journal of general virology 1998;79 ( Pt 1)():83-90.
1998: Smith G L; Vanderplasschen A
Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
Advances in experimental medicine and biology 1998;440():395-414.
1997: Smith G L; Symons J A; Khanna A; Vanderplasschen A; Alcamí A
Vaccinia virus immune evasion.
Immunological reviews 1997;159():137-54.
1997: Bayliss C D; Smith G L
Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity.
Nucleic acids research 1997;25(20):3984-90.
1997: Vanderplasschen A; Hollinshead M; Smith G L
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
The Journal of general virology 1997;78 ( Pt 8)():2041-8.
1997: Vanderplasschen A; Smith G L
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.
Journal of virology 1997;71(5):4032-41.
1997: Kettle S; Alcamí A; Khanna A; Ehret R; Jassoy C; Smith G L
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.
The Journal of general virology 1997;78 ( Pt 3)():677-85.
1996: Bayliss C D; Wilcock D; Smith G L
Stimulation of vaccinia virion DNA helicase I8R, but not A18R, by a vaccinia core protein L4R, an ssDNA binding protein.
The Journal of general virology 1996;77 ( Pt 11)():2827-31.
1996: Alcamí A; Smith G L
A mechanism for the inhibition of fever by a virus.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(20):11029-34.
1996: Alcamí A; Smith G L
Soluble interferon-gamma receptors encoded by poxviruses.
Comparative immunology, microbiology and infectious diseases 1996;19(4):305-17.
1996: Alcamí A; Smith G L
Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus.
Trends in microbiology 1996;4(8):321-6.
1996: Odell M; Kerr S M; Smith G L
Ligation of double-stranded and single-stranded [oligo(dT)] DNA by vaccinia virus DNA ligase.
Virology 1996;221(1):120-9.
1996: Wilcock D; Smith G L
Vaccinia virions lacking core protein VP8 are deficient in early transcription.
Journal of virology 1996;70(2):934-43.
1996: Sanderson C M; Parkinson J E; Hollinshead M; Smith G L
Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells.
Journal of virology 1996;70(2):905-14.
1996: Bayliss C D; Smith G L
Vaccinia virion protein I8R has both DNA and RNA helicase activities: implications for vaccinia virus transcription.
Journal of virology 1996;70(2):794-800.
1996: McIntosh A A; Smith G L
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
Journal of virology 1996;70(1):272-81.
1995: Parkinson J E; Sanderson C M; Smith G L
The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein.
Virology 1995;214(1):177-88.
1995: Alcamí A; Smith G L
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology.
Immunology today 1995;16(10):474-8.
1995: Blake N W; Kettle S; Law K M; Gould K; Bastin J; Townsend A R; Smith G L
Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
The Journal of general virology 1995;76 ( Pt 9)():2393-8.
1995: Alcamí A; Smith G L
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity.
Journal of virology 1995;69(8):4633-9.
1995: Symons J A; Alcamí A; Smith G L
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
Cell 1995;81(4):551-60.
1995: Kettle S; Blake N W; Law K M; Smith G L
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model.
Virology 1995;206(1):136-47.
1994: Parkinson J E; Smith G L
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
Virology 1994;204(1):376-90.
1994: Dixon L K; Twigg S R; Baylis S A; Vydelingum S; Bristow C; Hammond J M; Smith G L
Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1).
The Journal of general virology 1994;75 ( Pt 7)():1655-84.
1994: Wilcock D; Smith G L
Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation.
Virology 1994;202(1):294-304.
1994: Smith G L
Virus strategies for evasion of the host response to infection.
Trends in microbiology 1994;2(3):81-8.
1993: Banham A H; Smith G L
Characterization of vaccinia virus gene B12R.
The Journal of general virology 1993;74 ( Pt 12)():2807-12.
1993: Alcamí A; Smith G L
Comment on the paper by Shchelkunov et al. (1993) FEBS Letters 319, 80-83. Two genes encoding poxvirus cytokine receptors are disrupted or deleted in variola virus.
FEBS letters 1993;335(1):136-7; discussion 138.
1993: Vydelingum S; Baylis S A; Bristow C; Smith G L; Dixon L K
Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus.
The Journal of general virology 1993;74 ( Pt 10)():2125-30.
1993: Baylis S A; Twigg S R; Vydelingum S; Dixon L K; Smith G L
Three African swine fever virus genes encoding proteins with homology to putative helicases of vaccinia virus.
The Journal of general virology 1993;74 ( Pt 9)():1969-74.
1993: Smith G L
Vaccinia virus glycoproteins and immune evasion. The sixteenth Fleming Lecture.
The Journal of general virology 1993;74 ( Pt 9)():1725-40.
1993: Baylis S A; Banham A H; Vydelingum S; Dixon L K; Smith G L
African swine fever virus encodes a serine protein kinase which is packaged into virions.
Journal of virology 1993;67(8):4549-56.
1993: Engelstad M; Smith G L
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Virology 1993;194(2):627-37.
1993: Banham A H; Leader D P; Smith G L
Phosphorylation of ribosomal proteins by the vaccinia virus B1R protein kinase.
FEBS letters 1993;321(1):27-31.
1993: Dixon L K; Baylis S A; Vydelingum S; Twigg S R; Hammond J M; Hingamp P M; Bristow C; Wilkinson P J; Smith G L
African swine fever virus genome content and variability.
Archives of virology. Supplementum 1993;7():185-99.
1992: Banham A H; Smith G L
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions.
Virology 1992;191(2):803-12.
1992: Baylis S A; Dixon L K; Vydelingum S; Smith G L
African swine fever virus encodes a gene with extensive homology to type II DNA topoisomerases.
Journal of molecular biology 1992;228(3):1003-10.
1992: Aguado B; Selmes I P; Smith G L
Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus.
The Journal of general virology 1992;73 ( Pt 11)():2887-902.
1992: Alcamí A; Smith G L
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.
Cell 1992;71(1):153-67.
1992: Hammond J M; Kerr S M; Smith G L; Dixon L K
An African swine fever virus gene with homology to DNA ligases.
Nucleic acids research 1992;20(11):2667-71.
1992: Engelstad M; Howard S T; Smith G L
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
Virology 1992;188(2):801-10.
1992: Duncan S A; Smith G L
Vaccinia virus gene SalF5R is non-essential for virus replication in vitro and in vivo.
The Journal of general virology 1992;73 ( Pt 5)():1235-42.
1992: Moore J B; Smith G L
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.
The EMBO journal 1992;11(5):1973-80.
1992: Duncan S A; Smith G L
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.
Journal of virology 1992;66(3):1610-21.
1992: Law K M; Smith G L
A vaccinia serine protease inhibitor which prevents virus-induced cell fusion.
The Journal of general virology 1992;73 ( Pt 3)():549-57.
1991: Kerr S M; Johnston L H; Odell M; Duncan S A; Law K M; Smith G L
Vaccinia DNA ligase complements Saccharomyces cerevisiae cdc9, localizes in cytoplasmic factories and affects virulence and virus sensitivity to DNA damaging agents.
The EMBO journal 1991;10(13):4343-50.
1991: Hughes S J; Johnston L H; de Carlos A; Smith G L
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae.
The Journal of biological chemistry 1991;266(30):20103-9.
1991: Smith G L
Vaccinia virus vectors for gene expression.
Current opinion in biotechnology 1991;2(5):713-7.
1991: Smith G L; Chan Y S; Howard S T
Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat.
The Journal of general virology 1991;72 ( Pt 6)():1349-76.
1991: Smith G L; Chan Y S
Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily.
The Journal of general virology 1991;72 ( Pt 3)():511-8.
1991: Kerr S M; Smith G L
Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells.
Virology 1991;180(2):625-32.
1991: Howard S T; Chan Y S; Smith G L
Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family.
Virology 1991;180(2):633-47.
1991: Forrester A J; Sullivan V; Simmons A; Blacklaws B A; Smith G L; Nash A A; Minson A C
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
The Journal of general virology 1991;72 ( Pt 2)():369-75.
1990: Rodriguez J F; Smith G L
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.
Nucleic acids research 1990;18(18):5347-51.
1990: Zhou J; Crawford L; McLean L; Sun X Y; Stanley M; Almond N; Smith G L
Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.
The Journal of general virology 1990;71 ( Pt 9)():2185-90.
1990: Rodriguez J F; Smith G L
Inducible gene expression from vaccinia virus vectors.
Virology 1990;177(1):239-50.
1990: McLean C S; Churcher M J; Meinke J; Smith G L; Higgins G; Stanley M; Minson A C
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.
Journal of clinical pathology 1990;43(6):488-92.
1989: Howard S T; Smith G L
Two early vaccinia virus genes encode polypeptides related to protein kinases.
The Journal of general virology 1989;70 ( Pt 12)():3187-201.
1989: Kerr S M; Smith G L
Vaccinia virus encodes a polypeptide with DNA ligase activity.
Nucleic acids research 1989;17(22):9039-50.
1989: Smith G L; Chan Y S; Kerr S M
Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases.
Nucleic acids research 1989;17(22):9051-62.
1989: Smith G L; de Carlos A; Chan Y S
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping.
Nucleic acids research 1989;17(19):7581-90.
1989: Smith G L; Howard S T; Chan Y S
Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.
The Journal of general virology 1989;70 ( Pt 9)():2333-43.
1988: Browne H M; Churcher M J; Stanley M A; Smith G L; Minson A C
Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.
The Journal of general virology 1988;69 ( Pt 6)():1263-73.
1988: Sullivan V; Smith G L
The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization.
The Journal of general virology 1988;69 ( Pt 4)():859-67.
1988: Cranage M P; Smith G L; Bell S E; Hart H; Brown C; Bankier A T; Tomlinson P; Barrell B G; Minson T C
Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
Journal of virology 1988;62(4):1416-22.
1987: Sullivan V; Smith G L
Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.
The Journal of general virology 1987;68 ( Pt 10)():2587-98.
1987: Smith G L
Recombinant vaccinia viruses as live vaccines.
Haematology and blood transfusion 1987;31():362-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Geoffrey Smith

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Genes & Molecular Sequences

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Geoffrey Smith (preview)

All Publications